医疗系统人员对新冠疫苗接种的接受度调查
本研究调查了一家三级学术医疗中心成年员工和学生在疫苗获批3个月内的接种意愿,共3,347人参与。结果显示40.5%的医护人员打算延迟或拒绝接种,男性、既往流感疫苗接种、对新冠担忧增加及研究生教育程度与接种接受度相关。黑人受访者接种意愿更低。
要点
- 40.5%的医护人员计划延迟或拒绝新冠疫苗接种。
- 男性、既往流感疫苗接种、对新冠担忧增加及研究生教育程度与接种接受度相关。
- 黑人受访者接种犹豫更明显,仅24.8%计划3个月内接种。
核心结论
- 许多医护人员打算延迟或拒绝新冠疫苗接种,政策制定者应公正地解决对安全性、有效性、副作用、风险收益比和成本的担忧。
研究设计与样本
- 采用横断面调查设计,辅以多变量逻辑回归分析,研究对象为一家三级学术医疗中心的成年员工和学生,共18,250名合格者中3,347人参与。
主要发现
- 40.5%的医护人员打算延迟(30.6%)或拒绝(9.9%)接种疫苗。
- 多变量分析显示,男性(aOR 2.43;95%CI 2.00-2.95;P<.001)、既往流感疫苗接种(aOR 2.35;95%CI 1.75-3.18;P<.001)、对COVID-19担忧增加(aOR 2.40;95%CI 2.07-2.79;P<.001)和研究生教育(aOR 1.41;95%CI 1.21-1.65;P<.001)与疫苗接受度相关。
- 年龄、直接患者接触或自报总体健康状况与疫苗接受度无关。
- 接种障碍包括对长期副作用的担忧(57.1%)、安全性(55.0%)、有效性(37.1%)、风险收益比(31.0%)和成本(12.2%)。
- 黑人受访者亚组分析显示接种犹豫更高,仅24.8%计划3个月内接种(aOR 0.13;95%CI 0.08-0.21;P<.001)。
临床怎么用
- 临床工作中应关注医护人员对新冠疫苗的犹豫情绪,并针对安全性、有效性、副作用、风险收益比和成本等顾虑进行沟通。
局限性
- 研究仅纳入一家三级学术医疗中心的员工和学生,结果外推需谨慎。
- 原文指出急需对少数族裔亚组开展进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: One-third of the general public will not accept Coronavirus disease 2019 (COVID-19) vaccination but factors influencing vaccine acceptance among health care personnel (HCP) are not known. We investigated barriers and facilitators to vaccine acceptance within 3 months of regulatory approval (primary outcome) among adult employees and students at a tertiary-care, academic medical center. METHODS: We used a cross-sectional survey design with multivariable logistic regression. Covariates included age, gender, educational attainment, self-reported health status, concern about COVID-19, direct patient interaction, and prior influenza immunization. RESULTS: Of 18,250 eligible persons, 3,347 participated. Two in 5 (40.5%) HCP intend to delay (n = 1020; 30.6%) or forgo (n = 331; 9.9%) vaccination. Male sex (adjusted OR [aOR], 2.43; 95% confidence interval [CI], 2.00-2.95; P < .001), prior influenza vaccination (aOR, 2.35; 95% CI, 1.75-3.18; P < .001), increased concern about COVID-19 (aOR, 2.40; 95% CI, 2.07-2.79; P < .001), and postgraduate education (aOR, 1.41; 95% CI, 1.21-1.65; P < .001) - but not age, direct patient interaction, or self-reported overall health - were associated with vaccine acceptance in multivariable analysis. Barriers to vaccination included concerns about long-term side effects (n = 1197, 57.1%), safety (n = 1152, 55.0%), efficacy (n = 777, 37.1%), risk-to-benefit ratio (n = 650, 31.0%), and cost (n = 255, 12.2%).Subgroup analysis of Black respondents indicates greater hesitancy to accept vaccination (only 24.8% within 3 months; aOR 0.13; 95% CI, 0.08-0.21; P < .001). CONCLUSIONS: Many HCP intend to delay or refuse COVID-19 vaccination. Policymakers should impartially address concerns about safety, efficacy, side effects, risk-to-benefit ratio, and cost. Further research with minority subgroups is urgently needed.
引用
- Parente DJ, Ojo A, Gurley T, et al. Acceptance of COVID-19 Vaccination Among Health System Personnel. J Am Board Fam Med. 2021. PMID: 34088810. doi:10.3122/jabfm.2021.03.200541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。